.

New Deal

New Deal

Announced

15 Jun 2016

Completed

22 Nov 2016

CARBYLAN THERAPEUTICS INC / KALVISTA PHARMACEUTICALS LTD / Reverse Takeover / Public / £105m

Financials

Edit Data

Transaction Value-

Consideration Type-

Capital Owned-

Capital Bid For-

EV/Sales-

EV/EBITDA-

Share Price Premium-

One Off Charge-

target

Carbylan Therapeutics

bidder

Kalvista Pharmaceuticals

Sources

Edit

Tags

Edit

Reverse Takeover

Public

treatment development

specialty pharmaceuticals

Pharmaceuticals

Completed

Friendly

United States

Synopsis

Edit

Reverse merger of Carbylan Therapeutics, a developer of clinical-stage specialty pharmaceutical treatments, with KalVista Pharmaceuticals.

Service Providers (1)

Dealmakers

legal advisors

Latham & Watkins

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US